NCT06085677View on ClinicalTrials.gov

The Gastric HormonE BioMarkers of Preneoplastic Lesions Study

Not yet recruitingOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

November 4, 2023

Primary Completion Date

September 2, 2024

Study Completion Date

September 2, 2024

Conditions
Stomach NeoplasmChronic Atrophic GastritisIntestinal Metaplasia
All Listed Sponsors
collaborator

University College, London

OTHER

collaborator

University of Oxford

OTHER

collaborator

University of Copenhagen

OTHER

lead

Imperial College London

OTHER

NCT06085677 - The Gastric HormonE BioMarkers of Preneoplastic Lesions Study | Biotech Hunter | Biotech Hunter